Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cell Cycle Progression
100%
E2F Transcription Factor 1 (E2F1)
100%
Tetrahydrocannabinol
100%
Glioblastoma multiforme Cells
100%
Human Glioblastoma
100%
Cannabinoids
60%
Cyclin A
40%
Well-being
20%
Life Cycle Analysis
20%
Quantitative PCR
20%
Apoptosis
20%
Alleviation
20%
Tumor Regression
20%
Pharmacological Activities
20%
Cell Viability
20%
Western Blot Analysis
20%
Clinical Evaluation
20%
Brain Tumor
20%
Nausea
20%
Therapeutic Modalities
20%
Cell Contents
20%
Protease Inhibitors
20%
Active Components
20%
Proteasomal Degradation
20%
Anti-inflammatory Activity
20%
G1 Arrest
20%
U87MG
20%
Cell Progression
20%
P16INK4a
20%
Cell Growth Inhibition
20%
Cannabis Sativa
20%
Thymidylate Synthase
20%
U251
20%
Antitumoral Action
20%
Cell Cycle Inhibitors
20%
Cellular Contents
20%
Glioblastoma Cell Line
20%
Biochemistry, Genetics and Molecular Biology
E2F1
100%
Cell Cycle Progression
100%
down Regulation
100%
Tetrahydrocannabinol
100%
Cannabinoid
60%
Cell Cycle
40%
Cyclin A
40%
Transcription
20%
Wellbeing
20%
Western Blot
20%
Clinical Trial
20%
Proteasome Inhibitor
20%
Cell Viability
20%
Mediator
20%
G1/S Transition
20%
Antiinflammatory Activity
20%
Cell-Cycle Analysis
20%
U87
20%
Cell Growth
20%
Proteasome
20%
Growth Inhibition
20%
Thymidylate Synthase
20%
Cannabis Sativa
20%
Messenger RNA
20%
Programmed Cell Death
20%
Neuroscience
E2F1
100%
Glioblastoma Multiforme
100%
Cell Cycle Progression
100%
Tetrahydrocannabinol
100%
Cell Cycle
60%
Cannabinoid
60%
Cell Line
40%
Cyclin A
40%
Anti-Inflammatory
20%
Western Blot
20%
Proteasome
20%
G1 Phase Cell Cycle Checkpoint
20%
Cell Viability
20%
Thymidylate Synthase
20%
Cell Growth
20%
Cannabis Sativa
20%
Proteasome Inhibitor
20%
Intracranial Tumor
20%
Programmed Cell Death
20%
Messenger RNA
20%
Pharmacology, Toxicology and Pharmaceutical Science
Tetrahydrocannabinol
100%
Glioblastoma
100%
Dronabinol
100%
Cannabinoid
75%
Cyclin A
50%
Cell Viability
25%
Clinical Trial
25%
Western Blot
25%
Cannabis Sativa
25%
Anti-Inflammatory Drug
25%
Malignant Neoplasm
25%
Nausea
25%
Tumor Regression
25%
Thymidylate Synthase
25%
Proteasome Inhibitor
25%
Proteasome
25%
Messenger RNA
25%
Intracranial Tumor
25%
Cell-Cycle Analysis
25%